Madison M Rose

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Induced Apoptosis

Tyrosine Kinase

Metastatic Colorectal Cancer

Cell Proliferation

Top Venues

Cancer biology & therapy

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Hannah M Hicks, Veronica L Nassar, Jane Lund, Madison M Rose, Rebecca E Schweppe
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies. Cancer biology & therapy 25 (1) (2024)
Hannah M Hicks, Veronica L Nassar, Jane Lund, Madison M Rose, Rebecca E Schweppe
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies. Cancer biology & therapy 25 (1) (2024)
Hannah M Hicks, Veronica L Nassar, Jane Lund, Madison M Rose, Rebecca E Schweppe
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies. Cancer biology & therapy 25 (1) (2024)
Hannah M Hicks, Veronica L Nassar, Jane Lund, Madison M Rose, Rebecca E Schweppe
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies. Cancer biology & therapy 25 (1) (2024)
Madison M Rose, Veronica L Espinoza, Katelyn J Hoff, Laura A Pike, Vibha Sharma, Marie-Claude Hofmann, Aik Choon Tan, Nikita Pozdeyev, Rebecca E Schweppe
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer. Cancers 15 (2) (2023)
Madison M Rose, Kelsey W Nassar, Vibha Sharma, Rebecca E Schweppe
AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibition. Medical oncology (Northwood, London, England) 40 (10) (2023)
Eric L Bolf, Thomas C Beadnell, Madison M Rose, Angelo D'Alessandro, Travis Nemkov, Kirk C Hansen, Rebecca E Schweppe
Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity. Cells 12 (10) (2023)
Madison M Rose, Veronica L Espinoza, Katelyn J Hoff, Laura A Pike, Vibha Sharma, Marie-Claude Hofmann, Aik Choon Tan, Nikita Pozdeyev, Rebecca E Schweppe
BCL2L11 Induction Mediates Sensitivity to Src and MEK1/2 Inhibition in Thyroid Cancer. Cancers 15 (2) (2023)